American Association for Cancer Research (AACR)
@theaacr.bsky.social
The mission of the American Association for Cancer Research (AACR) is to prevent and cure cancer through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.
Some doctors still avoid using hormone therapy in women with gynecologic cancers, and crowdfunding falls short for people with cancer. Read these stories and more from Cancer Today magazine's The Week in Cancer News.
November 14: The Week in Cancer News | Cancer Today
Many doctors don’t prescribe hormone therapy in women with gynecologic cancers, and cancer-related crowdfunding often falls short of goals.
buff.ly
November 14, 2025 at 11:00 PM
Some doctors still avoid using hormone therapy in women with gynecologic cancers, and crowdfunding falls short for people with cancer. Read these stories and more from Cancer Today magazine's The Week in Cancer News.
With the AACR Special Conference on Cancer Evolution coming up on December 4-6, the #AACRBlog spoke with conference cochair @marasherman.bsky.social and AACR Cancer Evolution Working Group chair Laura M. Heiser about what to expect: buff.ly/qBq6LgO #AACRevol25
November 14, 2025 at 4:45 PM
With the AACR Special Conference on Cancer Evolution coming up on December 4-6, the #AACRBlog spoke with conference cochair @marasherman.bsky.social and AACR Cancer Evolution Working Group chair Laura M. Heiser about what to expect: buff.ly/qBq6LgO #AACRevol25
The abstract deadline for the AACR Annual Meeting 2026 is 11:59 PM ET on Tuesday, November 18. Submit an abstract and join the cancer research community in San Diego, April 17-22. Learn more:
buff.ly/dzZnhJr
#AACR26
buff.ly/dzZnhJr
#AACR26
November 14, 2025 at 2:25 PM
The abstract deadline for the AACR Annual Meeting 2026 is 11:59 PM ET on Tuesday, November 18. Submit an abstract and join the cancer research community in San Diego, April 17-22. Learn more:
buff.ly/dzZnhJr
#AACR26
buff.ly/dzZnhJr
#AACR26
Gene Regulatory Mechanisms of Oncoproteins:
Stephen Mack, Genevieve Kendall, Eleni Tomazou, and Brian Rubin will address this topic in a plenary session at the AACR Conference on Fusion-Positive Cancers (January 13-15, 2026; Philadelphia).
buff.ly/M5Tpi1K
#AACRfusion26 @kendalllab.bsky.social
Stephen Mack, Genevieve Kendall, Eleni Tomazou, and Brian Rubin will address this topic in a plenary session at the AACR Conference on Fusion-Positive Cancers (January 13-15, 2026; Philadelphia).
buff.ly/M5Tpi1K
#AACRfusion26 @kendalllab.bsky.social
November 13, 2025 at 5:47 PM
Gene Regulatory Mechanisms of Oncoproteins:
Stephen Mack, Genevieve Kendall, Eleni Tomazou, and Brian Rubin will address this topic in a plenary session at the AACR Conference on Fusion-Positive Cancers (January 13-15, 2026; Philadelphia).
buff.ly/M5Tpi1K
#AACRfusion26 @kendalllab.bsky.social
Stephen Mack, Genevieve Kendall, Eleni Tomazou, and Brian Rubin will address this topic in a plenary session at the AACR Conference on Fusion-Positive Cancers (January 13-15, 2026; Philadelphia).
buff.ly/M5Tpi1K
#AACRfusion26 @kendalllab.bsky.social
Tremendous progress against blood cancers in the past decade has significantly decreased blood cancer–related deaths, improved survival rates, and helped survivors live fuller lives. Learn about these advancements in the 2025 AACR #CancerProgressReport: buff.ly/B03pNXi
November 13, 2025 at 1:45 PM
Tremendous progress against blood cancers in the past decade has significantly decreased blood cancer–related deaths, improved survival rates, and helped survivors live fuller lives. Learn about these advancements in the 2025 AACR #CancerProgressReport: buff.ly/B03pNXi
Register by Dec 15 to get the lowest rates for the AACR Special Conference on Innovations in Prostate Cancer Research and Treatment (Jan 20-22; Boston), chaired by Peter Nelson, Elena Castro, Patrick Pilié, and Eliezer Van Allen. Learn more:
buff.ly/EXiV4Yr
#AACRprostate26 @vanallenlab.bsky.social
buff.ly/EXiV4Yr
#AACRprostate26 @vanallenlab.bsky.social
November 12, 2025 at 10:03 PM
Register by Dec 15 to get the lowest rates for the AACR Special Conference on Innovations in Prostate Cancer Research and Treatment (Jan 20-22; Boston), chaired by Peter Nelson, Elena Castro, Patrick Pilié, and Eliezer Van Allen. Learn more:
buff.ly/EXiV4Yr
#AACRprostate26 @vanallenlab.bsky.social
buff.ly/EXiV4Yr
#AACRprostate26 @vanallenlab.bsky.social
A career development grant from the AACR enabled Yale Cancer's Luisa Escobar-Hoyos, MSc, PhD, to secure two major multi-year federal grants for her pancreatic cancer research: Learn more in #AACRStories: www.aacr.org/about-the-aa... #PancreaticCancerAwarenessMonth
November 12, 2025 at 8:25 PM
A career development grant from the AACR enabled Yale Cancer's Luisa Escobar-Hoyos, MSc, PhD, to secure two major multi-year federal grants for her pancreatic cancer research: Learn more in #AACRStories: www.aacr.org/about-the-aa... #PancreaticCancerAwarenessMonth
An antibody-drug conjugate led to longer survival for women with early-stage HER2-positive breast when signs of cancer remained after neoadjuvant treatment. Learn more in Cancer Today magazine: buff.ly/tmHFi0Q
November 11, 2025 at 9:06 PM
An antibody-drug conjugate led to longer survival for women with early-stage HER2-positive breast when signs of cancer remained after neoadjuvant treatment. Learn more in Cancer Today magazine: buff.ly/tmHFi0Q
Submit an abstract by December 4 for the AACR Special Conference on Innovations in Kidney Cancer Research (March 13-16, 2026; Philadelphia), chaired by Eric Jonasch, M. Celeste Simon, Samra Turajlic, and Qing Zhang. Learn more:
buff.ly/IoqbeGk
#AACRkidney26 @turajliclab.bsky.social
buff.ly/IoqbeGk
#AACRkidney26 @turajliclab.bsky.social
November 11, 2025 at 6:37 PM
Submit an abstract by December 4 for the AACR Special Conference on Innovations in Kidney Cancer Research (March 13-16, 2026; Philadelphia), chaired by Eric Jonasch, M. Celeste Simon, Samra Turajlic, and Qing Zhang. Learn more:
buff.ly/IoqbeGk
#AACRkidney26 @turajliclab.bsky.social
buff.ly/IoqbeGk
#AACRkidney26 @turajliclab.bsky.social
Promising early-phase clinical trial results for several first-in-class therapeutics with innovative mechanisms of action and cutting-edge technologies were recently presented at #Targets25. Learn more on the #AACRBlog: buff.ly/hNZxH9V
November 11, 2025 at 3:24 PM
Promising early-phase clinical trial results for several first-in-class therapeutics with innovative mechanisms of action and cutting-edge technologies were recently presented at #Targets25. Learn more on the #AACRBlog: buff.ly/hNZxH9V
Submit an abstract by November 18 for the AACR Annual Meeting 2026 (April 17-22; San Diego), chaired by Paul S. Mischel and Alice T. Shaw. Learn more:
buff.ly/dzZnhJr
#AACR26
buff.ly/dzZnhJr
#AACR26
November 10, 2025 at 4:11 PM
Submit an abstract by November 18 for the AACR Annual Meeting 2026 (April 17-22; San Diego), chaired by Paul S. Mischel and Alice T. Shaw. Learn more:
buff.ly/dzZnhJr
#AACR26
buff.ly/dzZnhJr
#AACR26
Submit an abstract by December 1 for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more:
buff.ly/TUarANa
#AACRIO26
buff.ly/TUarANa
#AACRIO26
November 7, 2025 at 4:55 PM
Submit an abstract by December 1 for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more:
buff.ly/TUarANa
#AACRIO26
buff.ly/TUarANa
#AACRIO26
The @US_FDA approved the targeted monoclonal antibody therapy daratumumab and hyaluronidase-fihj as a monotherapy for adults with high-risk smoldering multiple myeloma: buff.ly/41VfCrM
FDA approves daratumumab and hyaluronidase-fihj for high-risk smolderi
On November 6, 2025, the Food and Drug Administration approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) for adults with high-
www.fda.gov
November 7, 2025 at 12:17 AM
The @US_FDA approved the targeted monoclonal antibody therapy daratumumab and hyaluronidase-fihj as a monotherapy for adults with high-risk smoldering multiple myeloma: buff.ly/41VfCrM
AACR Project GENIE is celebrating its 10th anniversary. Look back at the history, growth, and impact of this publicly accessible cancer registry that continues to support clinical decision-making and advance precision medicine: buff.ly/jNksCvu
November 6, 2025 at 10:05 PM
AACR Project GENIE is celebrating its 10th anniversary. Look back at the history, growth, and impact of this publicly accessible cancer registry that continues to support clinical decision-making and advance precision medicine: buff.ly/jNksCvu
Submit an abstract by December 8 for the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles), chaired by Andrew J. Aguirre, Channing J. Der, David S. Hong, and Kevan M. Shokat. Learn more:
buff.ly/KSYsLWC
#AACRras26
buff.ly/KSYsLWC
#AACRras26
November 6, 2025 at 5:06 PM
Submit an abstract by December 8 for the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles), chaired by Andrew J. Aguirre, Channing J. Der, David S. Hong, and Kevan M. Shokat. Learn more:
buff.ly/KSYsLWC
#AACRras26
buff.ly/KSYsLWC
#AACRras26
In a new episode of the Believe in Progress podcast, Rhett Austell shares his powerful story of facing cancer and recurrence, navigating fatherhood, and finding strength in the fight for his life. Listen to this heartfelt podcast out now: buff.ly/PsCkHGo
November 5, 2025 at 8:16 PM
In a new episode of the Believe in Progress podcast, Rhett Austell shares his powerful story of facing cancer and recurrence, navigating fatherhood, and finding strength in the fight for his life. Listen to this heartfelt podcast out now: buff.ly/PsCkHGo
Reposted by American Association for Cancer Research (AACR)
The @theaacr.bsky.social–Mark Foundation Chemistry in Cancer Research Grants are now accepting Letters of Intent!
We’re seeking bold, innovative approaches in chemistry and chemical biology to tackle the biggest challenges in cancer.
Learn more and apply: www.aacr.org/grants/aacr-...
We’re seeking bold, innovative approaches in chemistry and chemical biology to tackle the biggest challenges in cancer.
Learn more and apply: www.aacr.org/grants/aacr-...
November 5, 2025 at 1:13 PM
The @theaacr.bsky.social–Mark Foundation Chemistry in Cancer Research Grants are now accepting Letters of Intent!
We’re seeking bold, innovative approaches in chemistry and chemical biology to tackle the biggest challenges in cancer.
Learn more and apply: www.aacr.org/grants/aacr-...
We’re seeking bold, innovative approaches in chemistry and chemical biology to tackle the biggest challenges in cancer.
Learn more and apply: www.aacr.org/grants/aacr-...
Submit an abstract by November 6 for the AACR Special Conference on Innovations in Prostate Cancer Research and Treatment (Jan 20-22; Boston), chaired by Peter S. Nelson, Elena Castro, Patrick G. Pilié, and Eliezer M. Van Allen. Learn more:
buff.ly/MBBHFX7
#AACRprostate26 @vanallenlab.bsky.social
buff.ly/MBBHFX7
#AACRprostate26 @vanallenlab.bsky.social
November 5, 2025 at 5:05 PM
Submit an abstract by November 6 for the AACR Special Conference on Innovations in Prostate Cancer Research and Treatment (Jan 20-22; Boston), chaired by Peter S. Nelson, Elena Castro, Patrick G. Pilié, and Eliezer M. Van Allen. Learn more:
buff.ly/MBBHFX7
#AACRprostate26 @vanallenlab.bsky.social
buff.ly/MBBHFX7
#AACRprostate26 @vanallenlab.bsky.social
Reposted by American Association for Cancer Research (AACR)
Are you an early-career scientist ready to lead & connect? 🌟
Joining the @theaacr.bsky.social Associate Member Council has shaped my network & allowed me to advocate for scientists like me. Apply now to make an impact! 🔬💪
🗓️ Deadline: Nov 7
👉 Apply here: (lnkd.in/gy7rna6Z)
#AACR #ECR #AMC
Joining the @theaacr.bsky.social Associate Member Council has shaped my network & allowed me to advocate for scientists like me. Apply now to make an impact! 🔬💪
🗓️ Deadline: Nov 7
👉 Apply here: (lnkd.in/gy7rna6Z)
#AACR #ECR #AMC
November 5, 2025 at 12:31 AM
Are you an early-career scientist ready to lead & connect? 🌟
Joining the @theaacr.bsky.social Associate Member Council has shaped my network & allowed me to advocate for scientists like me. Apply now to make an impact! 🔬💪
🗓️ Deadline: Nov 7
👉 Apply here: (lnkd.in/gy7rna6Z)
#AACR #ECR #AMC
Joining the @theaacr.bsky.social Associate Member Council has shaped my network & allowed me to advocate for scientists like me. Apply now to make an impact! 🔬💪
🗓️ Deadline: Nov 7
👉 Apply here: (lnkd.in/gy7rna6Z)
#AACR #ECR #AMC
Alexander Drilon, Jolanta Grembecka, Jessica Jiyeong Lin, and Jia Luo will discuss "Translating Discoveries Toward New Therapies" in a plenary session at the AACR Conference on Fusion-Positive Cancers (January 13-15, 2026; Philadelphia). Learn more:
buff.ly/3jO4l4j
#AACRfusion26 @jia-luo.bsky.social
buff.ly/3jO4l4j
#AACRfusion26 @jia-luo.bsky.social
November 4, 2025 at 6:44 PM
Alexander Drilon, Jolanta Grembecka, Jessica Jiyeong Lin, and Jia Luo will discuss "Translating Discoveries Toward New Therapies" in a plenary session at the AACR Conference on Fusion-Positive Cancers (January 13-15, 2026; Philadelphia). Learn more:
buff.ly/3jO4l4j
#AACRfusion26 @jia-luo.bsky.social
buff.ly/3jO4l4j
#AACRfusion26 @jia-luo.bsky.social
Submit an abstract by November 18 for the AACR Annual Meeting 2026 (April 17-22; San Diego), chaired by Paul S. Mischel and Alice T. Shaw. Learn more:
buff.ly/dzZnhJr
#AACR26
buff.ly/dzZnhJr
#AACR26
November 4, 2025 at 5:12 PM
Submit an abstract by November 18 for the AACR Annual Meeting 2026 (April 17-22; San Diego), chaired by Paul S. Mischel and Alice T. Shaw. Learn more:
buff.ly/dzZnhJr
#AACR26
buff.ly/dzZnhJr
#AACR26
New findings that adding chemotherapy to osimertinib (Tagrisso) for advanced EGFR-positive non-small cell lung cancer may help clarify options for first-line treatment. Read more in Cancer Today. buff.ly/7zkmjKf
November 4, 2025 at 3:42 PM
New findings that adding chemotherapy to osimertinib (Tagrisso) for advanced EGFR-positive non-small cell lung cancer may help clarify options for first-line treatment. Read more in Cancer Today. buff.ly/7zkmjKf
Submit an abstract by November 6 for the AACR Special Conference on Innovations in Prostate Cancer Research and Treatment (Jan 20-22; Boston), chaired by Peter S. Nelson, Elena Castro, Patrick G. Pilié, and Eliezer M. Van Allen. Learn more:
buff.ly/MBBHFX7
#AACRprostate26 @vanallenlab.bsky.social
buff.ly/MBBHFX7
#AACRprostate26 @vanallenlab.bsky.social
November 3, 2025 at 7:26 PM
Submit an abstract by November 6 for the AACR Special Conference on Innovations in Prostate Cancer Research and Treatment (Jan 20-22; Boston), chaired by Peter S. Nelson, Elena Castro, Patrick G. Pilié, and Eliezer M. Van Allen. Learn more:
buff.ly/MBBHFX7
#AACRprostate26 @vanallenlab.bsky.social
buff.ly/MBBHFX7
#AACRprostate26 @vanallenlab.bsky.social
Register by November 3 to get the lowest available rates for the San Antonio Breast Cancer Symposium (December 9-12), directed by Carlos L. Arteaga and Virginia G. Kaklamani. Learn more:
buff.ly/sLYTMHh
#SABCS25
buff.ly/sLYTMHh
#SABCS25
November 3, 2025 at 2:03 PM
Register by November 3 to get the lowest available rates for the San Antonio Breast Cancer Symposium (December 9-12), directed by Carlos L. Arteaga and Virginia G. Kaklamani. Learn more:
buff.ly/sLYTMHh
#SABCS25
buff.ly/sLYTMHh
#SABCS25
People with a history of polyps often do not get follow-up colonoscopy after a positive FIT test, early-onset cancers are rising in Corn Belt states, and more. Read these stories and more from Cancer Today magazine's Week in Cancer News. www.cancertodaymag.org/cancer-talk/...
October 31, 2025 at 7:59 PM
People with a history of polyps often do not get follow-up colonoscopy after a positive FIT test, early-onset cancers are rising in Corn Belt states, and more. Read these stories and more from Cancer Today magazine's Week in Cancer News. www.cancertodaymag.org/cancer-talk/...